European Medicines Agency - Regulatory - Regulation of medicines

D - Description



  Description

Name

EPLTN - European Paediatric Liver Transplantation Network

Year of foundation 2012 (foundation of EPLTN)
Preterm and/or term newborn Yes
Infants from 1 month to less than 24 months of age Yes
Children from 2 years to less than 12 years of age Yes
Adolescents from 12 years to less than 18 years Yes
Paediatric age ranges of study participants covered by the network 0-18 years
Multispeciality? Specify Specialties like paediatric oncology or immunology are targeted when relevant / related to paediatric hepatology
Speciality/disease specific? Specify Specialty specific: paediatric hepatology with a focus on paediatric liver transplantation and its comorbidities
Conditions covered? Specify Pre-transplant conditions: e.g. hepatic nutritional deficiency, hepatic metabolic bone disease, cirrhotic cardiomyopathy; Post-transplant conditions: graft rejection, graft fibrosis, post-transplant lymphoproliferative disorder, post-transplant cardiovascular disease, post-transplant renal disease
Procedure/Intervention specific? Specify liver transplantation
Number of collaborating countries 7
List of collaborating countries Germany, France, Spain, Italy, Switzerland, Poland, UK
Number of collaborating centres 7
List of collaborating centres Service d'Hépatologie-Gastroentérologie-Nutrition, Hôpital Necker-Enfants malades, Paris, France Paeditric Liver, GI and Transplantation Ospedali Riuniti di Bergamo, Bergamo, Italy Dept. Pédiatrie, Serv. spécialités pédiatriques, Université de Genève, Genève, Switzerland Servicio de Hepatología y Trasplante Hospital Infantil Universitario La Paz Madrid, Madrid, Spain Liver Unit, Birmingham Children's Hospital, Birmingham, UK Centrum Zdrowia Dziecka, Warszawa, Poland Paediatric Hepatology and Gastroenterology, Hannover Medical School, Hannover, Germany
Type of activity/studies
Clinical Studies Yes
Experimental research No
Other activity Development of clinical guidelines for practitioners; e.g. shared protocols for immunosuppression after liver transplantation